Bringing Awareness to Breast Cancer in October

Breast cancer can be a scary diagnosis. Even though mortality rates have declined in recent years in the United States, it is estimated that over 40,000 women and roughly 500 men will die from breast cancer in 2019. Despite progress in developing new treatment modalities for patients with this disease, there is still substantial work to be done in the field.

Read More

Research Highlights from the San Antonio Breast Cancer Symposium 2018

The 41st San Antonio Breast Cancer Symposium, held Dec. 4-8, drew more than 7,500 attendees from more than 90 countries. The Symposium offered the latest clinical, translational, and basic research, providing a forum for interaction and communication among researchers, health professionals, and those with a special interest in breast cancer.

Read More

SABCS Marks 40 Years

Kent Osborne, MD, a codirector of SABCS, wrote a guest post for Cancer Research Catalyst in 2015 that details the symposium’s growth. We’re happy to present it again. Check back with Cancer Research Catalyst frequently for updates from SABCS, which will take place Dec. 5-9.

Read More

SABCS 2016: Extended Letrozole Therapy May Have Limited Benefits

Data presented at the San Antonio Breast Cancer Symposium showed that five additional years of the aromatase inhibitor (AI) therapy letrozole (Femara) following an initial five years of AI-based adjuvant hormone therapy did not significantly improve survival outcomes in postmenopausal women with early-stage HR-positive breast cancer. The additional five years did improve some outcomes related to recurrence.

Read More

SABCS 2016: Co-director Carlos L. Arteaga, MD, Previews Breast Cancer Symposium

SABCS is a comprehensive scientific meeting that provides the latest information on prevention, diagnosis, and treatment of breast cancer and premalignant breast disease to various stakeholders in the field.

Read More

Increasing Awareness of Breast Cancer Health Disparities

This month is Breast Cancer Awareness Month, a type of cancer against which we have made much progress. However, a recent report from the Centers for Disease Control and Prevention (CDC) highlights that the progress we are making has not been uniform for all segments of the population.

Read More